Supon Limwattananon และผู้แต่งคนอื่นๆ. (2005) Cost-Effectiveness Analysis of Celecoxib on an Avoidance of Gastrointestinal Adverse Events in Patients with Osteoarthritis. <i>Isan Journal ofPharmaceutical Sciences</i>, <i>1</i>(2), 15-29.Supon Limwattananon และผู้แต่งคนอื่นๆ. "Cost-Effectiveness Analysis of Celecoxib on an Avoidance of Gastrointestinal Adverse Events in Patients with Osteoarthritis". Isan Journal ofPharmaceutical Sciences 1 (2005):15-29.Supon Limwattananon และผู้แต่งคนอื่นๆ. Cost-Effectiveness Analysis of Celecoxib on an Avoidance of Gastrointestinal Adverse Events in Patients with Osteoarthritis. Faculty of Pharmaceutical Sciences KKU MSU UBU:ม.ป.ท. 2005.